ProPhase Labs, Inc. — Director's Dealing 2020

Mar 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2020-03-26

Reporting Person: GLECKEL LOUIS MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-26	Common Stock, par value $0.0005	P	100000	$1.75	Acquired	209894	Direct